The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.
Copyright 2025 NPR
© 2025 Public Radio East
Public Radio For Eastern North Carolina
89.3 WTEB New Bern 88.5 WZNB New Bern 91.5 WBJD Atlantic Beach
90.3 WKNS Kinston 89.9 W210CF Greenville
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations